Interstitial Lung Disease Research Unit Biobank

Last updated: October 7, 2024
Sponsor: University of Kansas Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pneumonia

Lung Injury

Allergy

Treatment

N/A

Clinical Study ID

NCT05392881
STUDY00144558
  • Ages > 18
  • All Genders

Study Summary

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)

  2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.

  3. The participant is ≥ 18 years of age.

  4. The participant has signed an approved consent for this study (living patients only)

Study Design

Total Participants: 1000
Study Start date:
August 09, 2021
Estimated Completion Date:
March 01, 2032

Study Description

The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Research Unit (ILDRU) repository and database to help develop new methods for early diagnosis, uncover underlying genetic and environmental risk factors, as well as potential treatment targets in the broad range of interstitial lung diseases and rare lung diseases (RLD).

Connect with a study center

  • The University of Kansas Medical Center

    Kansas City, Kansas 66160
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.